Previous studies have shown that shorter TTE is valuable to differentiate malignant from benign breast lesions and correlates with tumor aggressiveness, high grade, HR negativity, HER2 positivity, and triple-negative subtype [21, 36–38]. The gene discussed is ERBB2; the disease is neoplasm.